Bilateral Intravitreal Ranibizumab Injection and Panretinal Photocoagulation in a 16-Year-Old Girl with Severe Vaso-Occlusive Lupus Retinopathy | Zendy

Hasan Can Doruk | Zendy; P. Cetin | Zendy; Fatoş Önen | Zendy; Ali Osman Saatçi | Zendy

Open Access

Bilateral Intravitreal Ranibizumab Injection and Panretinal Photocoagulation in a 16-Year-Old Girl with Severe Vaso-Occlusive Lupus Retinopathy

Author(s) -

Hasan Can Doruk,

P. Cetin,

Fatoş Önen,

Ali Osman Saatçi

Publication year - 2013

Publication title -

case reports in ophthalmological medicine

Language(s) - English

Resource type - Journals

eISSN - 2090-6722

pISSN - 2090-6730

DOI - 10.1155/2013/817186

Subject(s) - medicine , ranibizumab , ophthalmology , panretinal photocoagulation , retinopathy , systemic lupus erythematosus , vitreous hemorrhage , serous fluid , retinal , surgery , bevacizumab , retinal detachment , diabetic retinopathy , chemotherapy , disease , diabetes mellitus , endocrinology

A 16-year-old girl with fever of unknown origin and bilateral vaso-occlusive retinopathy with retinal neovascularization, preretinal hemorrhage, and serous macular detachment was treated with single bilateral 0.5 mg intravitreal ranibizumab injection prior to aggressive PRP with success. No systemic steroids or immunosuppressive therapy was employed at that time. She received the diagnosis of “systemic lupus erythematosus” five years after this episode with further systemic symptoms. In certain cases with vaso-occlusive type of lupus retinopathy, anti-VEGF agents may be administered in addition to panretinal photocoagulation to achieve better visual and anatomic outcome.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research